Clinical Research Directory
Browse clinical research sites, groups, and studies.
Exceptional Responders With Solid Tumor Cancer to Chemotherapy
Sponsor: Adera Labs, LLC
Summary
This is an observational study enrolling patients with Solid Tumor cancers to identify genomic expression differences between exceptional responders and non-responders to standard of care chemotherapy. Data analysis of the gene expression profile of the exceptional responders compared to non-responders will define genomic patterns that may help understand their response to chemotherapy.
Official title: Evaluation of Exceptional Responders With Solid Tumor Cancer
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
250
Start Date
2015-10
Completion Date
2027-08
Last Updated
2023-02-01
Healthy Volunteers
No
Conditions
Interventions
Standard of Care Chemotherapy
Physician's Choice Chemotherapy Treatment (non-guided)
Locations (1)
The Pancreatic Cancer Treatment Center of Los Angeles
Los Angeles, California, United States